Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs Trip.com Group Ltd (TCOM) Price & Performance

AstraZeneca plcTrade
Trip.com Group LtdTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs Trip.com Group Ltd — how do they compare? AstraZeneca plc trades at $158.1 (market cap $250.84B), while Trip.com Group Ltd trades at $46.03 (market cap $29.26B). The key difference: AstraZeneca plc is far larger — about 8.6× Trip.com Group Ltd's market cap, and AstraZeneca plc pays the higher dividend (1.97%). Which is the better fit depends on your goals.

AZNTCOM
Market Cap
$250.84B$29.26B
Sector
HealthConsumer Cyclical
52-Week High
$209.48$78.96
52-Week Low
$147.06$39.84
Enterprise Value
$278.12B$21.91B
Dividend Yield
1.97%0.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About Trip.com Group Ltd

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

Read more on TCOM